Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
98.84
-1.21 (-1.21%)
At close: Feb 11, 2026, 4:00 PM EST
99.49
+0.65 (0.66%)
After-hours: Feb 11, 2026, 7:53 PM EST

Incyte Revenue

In the year 2025, Incyte had annual revenue of $5.14B with 21.22% growth. Incyte had revenue of $1.51B in the quarter ending December 31, 2025, with 27.84% growth.

Revenue (ttm)
$5.14B
Revenue Growth
+21.22%
P/S Ratio
3.75
Revenue / Employee
$1,807,750
Employees
2,844
Market Cap
19.67B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.14B900.03M21.22%
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 20202.67B507.94M23.53%
Dec 31, 20192.16B276.88M14.71%
Dec 31, 20181.88B345.67M22.50%
Dec 31, 20171.54B430.50M38.93%
Dec 31, 20161.11B351.97M46.70%
Dec 31, 2015753.75M242.26M47.36%
Dec 31, 2014511.50M508.45M16,696.72%
Dec 31, 20133.05M-294.01M-98.97%
Dec 31, 2012297.06M202.60M214.50%
Dec 31, 201194.46M-75.42M-44.40%
Dec 31, 2010169.88M160.61M1,733.55%
Dec 31, 20099.27M5.35M136.41%
Dec 31, 20083.92M-30.52M-88.62%
Dec 31, 200734.44M6.80M24.59%
Dec 31, 200627.64M19.80M252.32%
Dec 31, 20057.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Genmab3.85B
BioNTech SE3.70B
Royalty Pharma2.38B
Moderna2.23B
Ionis Pharmaceuticals966.96M
Ascendis Pharma758.59M
Insmed447.02M
BridgeBio Pharma353.78M
Revenue Rankings